First Time Loading...

Coloplast A/S
OTC:CLPBF

Watchlist Manager
Coloplast A/S Logo
Coloplast A/S
OTC:CLPBF
Watchlist
Price: 119.5 USD Market Closed
Updated: May 3, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Coloplast A/S

Revenue
25B DKK
Cost of Revenue
-8.3B DKK
Gross Profit
16.7B DKK
Operating Expenses
-9.8B DKK
Operating Income
6.9B DKK
Other Expenses
-2B DKK
Net Income
4.9B DKK

Margins Comparison
Coloplast A/S Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
DK
Coloplast A/S
CSE:COLO B
191.9B DKK
67%
28%
19%
JP
Hoya Corp
TSE:7741
6.4T JPY
86%
28%
22%
CH
Alcon AG
SIX:ALC
35.3B CHF
56%
12%
10%
US
Align Technology Inc
NASDAQ:ALGN
21.6B USD
70%
17%
12%
US
Cooper Companies Inc
NYSE:COO
17.8B USD
66%
15%
8%
KR
HLB Inc
KOSDAQ:028300
13.8T KRW
-2%
-291%
-441%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
55.6B CNY
73%
45%
42%
UK
ConvaTec Group PLC
LSE:CTEC
5.1B GBP
159%
116%
6%
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
5.9B USD
53%
7%
-3%
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.4B USD
55%
29%
25%
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF
32%
16%
14%
Country DK
Market Cap 191.9B DKK
Gross Margin
67%
Operating Margin
28%
Net Margin
19%
Country JP
Market Cap 6.4T JPY
Gross Margin
86%
Operating Margin
28%
Net Margin
22%
Country CH
Market Cap 35.3B CHF
Gross Margin
56%
Operating Margin
12%
Net Margin
10%
Country US
Market Cap 21.6B USD
Gross Margin
70%
Operating Margin
17%
Net Margin
12%
Country US
Market Cap 17.8B USD
Gross Margin
66%
Operating Margin
15%
Net Margin
8%
Country KR
Market Cap 13.8T KRW
Gross Margin
-2%
Operating Margin
-291%
Net Margin
-441%
Country CN
Market Cap 55.6B CNY
Gross Margin
73%
Operating Margin
45%
Net Margin
42%
Country UK
Market Cap 5.1B GBP
Gross Margin
159%
Operating Margin
116%
Net Margin
6%
Country US
Market Cap 5.9B USD
Gross Margin
53%
Operating Margin
7%
Net Margin
-3%
Country US
Market Cap 5.4B USD
Gross Margin
55%
Operating Margin
29%
Net Margin
25%
Country CH
Market Cap 4.5B CHF
Gross Margin
32%
Operating Margin
16%
Net Margin
14%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Coloplast A/S Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DK
Coloplast A/S
CSE:COLO B
191.9B DKK
46%
12%
25%
14%
JP
Hoya Corp
TSE:7741
6.4T JPY
20%
16%
23%
29%
CH
Alcon AG
SIX:ALC
35.3B CHF
5%
3%
4%
5%
US
Align Technology Inc
NASDAQ:ALGN
21.6B USD
13%
8%
17%
9%
US
Cooper Companies Inc
NYSE:COO
17.8B USD
4%
2%
5%
3%
KR
HLB Inc
KOSDAQ:028300
13.8T KRW
-33%
-22%
-17%
-19%
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
55.6B CNY
24%
22%
25%
38%
UK
ConvaTec Group PLC
LSE:CTEC
5.1B GBP
8%
4%
79%
61%
US
DENTSPLY SIRONA Inc
NASDAQ:XRAY
5.9B USD
-4%
-2%
5%
3%
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.4B USD
52%
22%
29%
33%
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF
13%
8%
14%
9%
Country DK
Market Cap 191.9B DKK
ROE
46%
ROA
12%
ROCE
25%
ROIC
14%
Country JP
Market Cap 6.4T JPY
ROE
20%
ROA
16%
ROCE
23%
ROIC
29%
Country CH
Market Cap 35.3B CHF
ROE
5%
ROA
3%
ROCE
4%
ROIC
5%
Country US
Market Cap 21.6B USD
ROE
13%
ROA
8%
ROCE
17%
ROIC
9%
Country US
Market Cap 17.8B USD
ROE
4%
ROA
2%
ROCE
5%
ROIC
3%
Country KR
Market Cap 13.8T KRW
ROE
-33%
ROA
-22%
ROCE
-17%
ROIC
-19%
Country CN
Market Cap 55.6B CNY
ROE
24%
ROA
22%
ROCE
25%
ROIC
38%
Country UK
Market Cap 5.1B GBP
ROE
8%
ROA
4%
ROCE
79%
ROIC
61%
Country US
Market Cap 5.9B USD
ROE
-4%
ROA
-2%
ROCE
5%
ROIC
3%
Country US
Market Cap 5.4B USD
ROE
52%
ROA
22%
ROCE
29%
ROIC
33%
Country CH
Market Cap 4.5B CHF
ROE
13%
ROA
8%
ROCE
14%
ROIC
9%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More